# Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

> **NCT06384248** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Letolab** · enrollment: 30 (estimated)

## Conditions studied

- Unresectable or Metastatic Sarcoma

## Interventions

- **DRUG:** LTC004

## Key facts

- **NCT ID:** NCT06384248
- **Lead sponsor:** Letolab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-26
- **Primary completion:** 2025-12-28
- **Final completion:** 2025-12-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06384248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06384248, "Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06384248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*